Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
Croatian Medical Journal|May 3, 2021
B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host diseaseAntonija Babić, Lejla Kurić, Ana Zelić Kerep, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejectionJacopo Mariotti, Jason Foley, Unsu Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomasMichael R Bishop, Jeannie Whit-Shan Hou, Wyndham H Wilson, et al.
Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.
Autophagy|April 21, 2010
Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHDShoba Amarnath, Francis A Flomerfelt, Carliann M Costanzo, et al.
Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.
Blood Advances|May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 studyNoa G Holtzman, Annie Im, Lauren M Curtis, et al.
Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.
The Journal of Rheumatology|March 3, 2004
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTRJohn A Snowden, Jakob Passweg, John J Moore, et al.
Haematologica|June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Pageof 26